The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer.
Hazel R. Scott,Donald C. McMillan,L M Forrest,Duncan J.F Brown,Colin S. McArdle,Robert Milroy +5 more
Reads0
Chats0
TLDR
The results indicate that the majority of patients with inoperable non-small cell lung cancer have evidence of a systemic inflammatory response and an increase in the magnitude of the systemicinflammatory response resulted in greater weight loss, poorer performance status, more fatigue and poorer survival.Abstract:
The relationship between the magnitude of systemic inflammatory response and the nutritional/functional parameters in patients with inoperable non-small cell lung cancer were studied The extent of weight loss, albumin, C-reactive protein, performance status and quality of life was measured in 106 patients with inoperable non-small cell lung cancer (stages III and IV) Survival analysis was performed using the Cox proportional hazard model The majority of patients were male and almost 80% had elevated circulating C-reactive protein concentrations (>10 mg x l(-1)) On multivariate analysis, age (P=0012), tumour type (0002), weight loss (P=0056), C-reactive protein (P=0047), Karnofsky performance status (P=0002) and fatigue (P=0046) were independent predictors of survival The patients were grouped according to the magnitude of the C-reactive protein concentrations ( 100 mg x l(-1)) An increase in the magnitude of the systemic inflammatory response was associated with increased weight loss (P=0004), reduced albumin concentrations (P=0001), reduced performance status (P=0060), increased fatigue (P=0011) and reduced survival (HR 1936 95%CI 1414-2650, P<0001) These results indicate that the majority of patients with inoperable non-small cell lung cancer have evidence of a systemic inflammatory response Furthermore, an increase in the magnitude of the systemic inflammatory response resulted in greater weight loss, poorer performance status, more fatigue and poorer survivalread more
Citations
More filters
Journal ArticleDOI
Proinflammatory cytokine levels in oral lichen planus, oral leukoplakia, and oral submucous fibrosis.
Jasdeep Kaur,Reinhilde Jacobs +1 more
TL;DR: Salivary and serum IL-8, IL-6, and TNF-α levels might act as diagnostic markers for detection of oral precancer.
Journal ArticleDOI
Preoperative C-reactive protein levels are associated with tumor size and lymphovascular invasion in resected non-small cell lung cancer
Jin Gu Lee,Byoung Chul Cho,Mi Kyung Bae,Chang Young Lee,In-Kyu Park,Dae Joon Kim,Song Vogue Ahn,Kyung Young Chung +7 more
TL;DR: Results indicate that lymphovascular invasion and pathologic tumor size are associated with preoperative serum CRP level, which may be considered a prognostic factor in patients with NSCLC.
Journal ArticleDOI
The dynamic change of neutrophil to lymphocyte ratio can predict clinical outcome in stage I-III colon cancer
TL;DR: The delta-NLR was an independent prognostic factor for overall survival in early stage colon cancer and patients with increased delta- NLR had an favourable clinical outcome.
Journal ArticleDOI
Effect of celecoxib on survival in patients with advanced non-small cell lung cancer : A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group
Andrea Koch,Bengt Bergman,Bengt Bergman,Erik Holmberg,Christer Sederholm,Lars Ek,Jaroslaw Kosieradzki,Kristina Lamberg,Lars Thaning,Sven-Olof Ydreborg,Sverre Sörenson +10 more
TL;DR: This study failed to demonstrate a survival benefit of the addition of celecoxib to palliative chemotherapy, and small but not statistically significant differences in global quality of life and pain were seen favouring the cele Coxib group.
References
More filters
Journal ArticleDOI
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
Neil K. Aaronson,Sam H Ahmedzai,Bengt Bergman,Monika Bullinger,Ann Cull,Nicole Duez,Antonio Filiberti,Henning Flechtner,Stewart B. Fleishman,Johanna C. J. M. de Haes,Stein Kaasa,M. Klee,David Osoba,Darius Razavi,Peter B. Rofe,Simon Schraub,Kommer C. A. Sneeuw,Marianne Sullivan,Fumikazu Takeda +18 more
TL;DR: The reliability and validity of the EORTC QLQ-C30 questionnaire were highly consistent across the three language-cultural groups studied: patients from English-speaking countries, Northern Europe, and Southern Europe.
Journal ArticleDOI
A new international staging system for lung cancer
TL;DR: The International Staging System for Lung Cancer provides for classification of six levels of disease extent in five stage groups that relate to patient management and prognosis and can be readily applied in a broad spectrum of clinical and teaching environments.
Journal ArticleDOI
The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting.
TL;DR: The utility of the Karnofsky Performance Status Scale as a valuable research tool when employed by trained observers is suggested and the relationship of the KPS to longevity in a population of terminal cancer patients documents its predictive validity.
Journal ArticleDOI
The new International Staging System for Lung Cancer.
TL;DR: The International Staging System for Lung Cancer provides for classification of six levels of disease extent in five stage groups that relate to patient management and prognosis and can be readily applied in a broad spectrum of clinical and teaching environments.
Journal ArticleDOI
Acute-phase protein response and survival duration of patients with pancreatic cancer.
J. S. Falconer,Kenneth C. H. Fearon,James A. Ross,R. Elton,Stephen J. Wigmore,O. J. Garden,David Carter +6 more
TL;DR: Whether certain nutritional indices and the acute‐phase protein response are prognostic factors independent of disease stage for patients with unresectable pancreatic cancer are determined.
Related Papers (5)
Systemic inflammatory response predicts survival following curative resection of colorectal cancer.
Prognostic effect of weight loss prior tochemotherapy in cancer patients
William D. Dewys,Colin B. Begg,Philip T. Lavin,Pierre R. Band,John M. Bennett,Joseph R. Bertino,Martin H. Cohen,Harold O. Douglass,Paul F. Engstrom,Ediz Z. Ezdinli,John Horton,Gerhard J. Johnson,Charles G. Moertel,Martin M. Oken,Charles P. Perlia,Charles Rosenbaum,Murray N. Silverstein,Roland T. Skeel,Robert W. Sponzo,Douglass C. Tormey +19 more